Concepedia

Dmitry Gultyaev

DG

Statistics

Publications

6

Citations

163

H-Index

6

Active since

2006

Affiliations

Allergan (United States)(Current)

University College London

Allergan (United Kingdom)

Sanofi (United States)

Dmitry Gultyaev is an author at Allergan (United States) specializing in cost-effectiveness analysis, pharmacoeconomics, and pharmacy.

Publications per year

2006–2021

6

Publications

6

Development and Validation of the Economic Assessment of Glycemic Control and Long-Term Effects of Diabetes (EAGLE) Model

E Mueller, Stefanie Maxion‐Bergemann, Dmitry Gultyaev et al. · Diabetes Technology & Therapeutics · 2006 · 57 citations

, , +17

Cost–effectiveness of overactive bladder treatments: from the US payer perspective

Brian Murray, Sam Hessami, Dmitry Gultyaev et al. · Journal of Comparative Effectiveness Research · 2018 · 35 citations · Full text

, , +16

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia

Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser et al. · Journal of health economics and outcomes research · 2021 · 26 citations · Full text

, , +17

Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population

Jie Meng, Roman Casciano, Yi‐Chien Lee et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 20 citations · Full text

, , +17

OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales

Nick Freemantle, Kristin Khalaf, C. Loveman et al. · The European Journal of Health Economics · 2015 · 14 citations · Full text

, , +16

1–5 of 6